Drug allergy laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
* [[Histamine]] levels may be elevated after an acute reaction, but is unreliable for [[diagnosis]].
* [[Histamine]] levels may be elevated after an acute reaction, but is unreliable for [[diagnosis]].
* [[Skin testing]] for drug-specific [[IgE]]. Only for type I allergic reactions.
* [[Skin testing]] for drug-specific [[IgE]]. Only for type I allergic reactions.
* In-vitro tests for immediate drug reactions are available, but are largely considered investigational.
* [[In-vitro]] tests for immediate drug reactions are available, but are largely considered investigational.
*Patch testing to test for a type IV reaction where drugs are mixed into petrolatum and applied to the skin for 48 hours. This test is useful in evaluating patients with maculopapular exanthema, acute generalized exanthematous pustulosis, and flexular exanthema. It is not to be used in patients with a history of Stevens-johnson syndrome or toxic epidermal necrolysis.
*Patch testing to test for a type IV reaction where drugs are mixed into petrolatum and applied to the skin for 48 hours. This test is useful in evaluating patients with maculopapular exanthema, acute generalized exanthematous pustulosis, and flexular exanthema. It is not to be used in patients with a history of Stevens-johnson syndrome or toxic epidermal necrolysis.
* Intradermal testing with delayed readout is more [[sensitive]] than a patch test, and involves injection a small amount of the [[allergen]] dissolved in water, under the skin. A [[prick test]] should be done beforehand, and the concentration used should be non-irritating.
* Intradermal testing with delayed readout is more sensitive than a patch test, and involves [[injection]] of a small amount of the allergen dissolved in water, under the skin. A prick test should be done beforehand, and the concentration used should be non-irritating.

Revision as of 19:22, 13 August 2012


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]

Drug Allergy

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Drug allergy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Drug allergy laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Drug allergy laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Drug allergy laboratory findings

CDC on Drug allergy laboratory findings

Drug allergy laboratory findings in the news

Blogs on Drug allergy laboratory findings

Directions to Hospitals Treating Drug allergy

Risk calculators and risk factors for Drug allergy laboratory findings

Overview

Laboratory Findings

  • Erythrocyte sedimentation rate (ESR) may be increased.
  • White blood cell (WBC) may be increased.
  • Urine eosinophils may be increased, especially in cases of allergic interstitial nephritis.
  • Blood eosinophils may be increased.
  • Liver function tests (LFT)'s may be increased.
  • Elevations in tryptase may be seen detected in serum or plasma within several hours after an acute allergic event, and is consistent with anaphylaxis.
  • Histamine levels may be elevated after an acute reaction, but is unreliable for diagnosis.
  • Skin testing for drug-specific IgE. Only for type I allergic reactions.
  • In-vitro tests for immediate drug reactions are available, but are largely considered investigational.
  • Patch testing to test for a type IV reaction where drugs are mixed into petrolatum and applied to the skin for 48 hours. This test is useful in evaluating patients with maculopapular exanthema, acute generalized exanthematous pustulosis, and flexular exanthema. It is not to be used in patients with a history of Stevens-johnson syndrome or toxic epidermal necrolysis.
  • Intradermal testing with delayed readout is more sensitive than a patch test, and involves injection of a small amount of the allergen dissolved in water, under the skin. A prick test should be done beforehand, and the concentration used should be non-irritating.